Biomemory leverages molecular engineering to build exabyte appliances for data centers
Biomemory has raised $18.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
Biomemory's investors include Bpifrance, Blast. Club, eureKARE, Crédit Mutuel Innovation, AGORANOV.
Biomemory is headquartered in Paris, France.
Biomemory leverages molecular engineering to build exabyte appliances for data centers
Biomemory is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biomemory — Funding & Investors." VCBacked, December 9, 2024, https://www.vcbacked.co/company/biomemory. Accessed July 25, 2026.
VCBacked. (2024). Biomemory — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/biomemory
{{cite web |title=Biomemory — Funding & Investors |url=https://www.vcbacked.co/company/biomemory |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated